Health
Genethon develops gene therapy for treating Duchenne muscular dystrophy – News-Medical.net
Genethon, dedicated to designing and developing gene therapy products for rare diseases, received this Monday 30th of November the authorization from the ANSM,…
Genethon, dedicated to designing and developing gene therapy products for rare diseases, received this Monday 30th of November the authorization from the ANSM, the French National Agency for Medicines and Health Products Safety, to start in France a multicentre international clinical trial for the treatment of Duchenne muscular dystrophy with product GNT 004.
This trial’s goal is to assess the safety and efficacy of an innovative gene therapy designed at Genethon, combining an AAV-type viral vector…
-
Noosa News20 hours agoRallies under way as nationwide support for Palestine surges
-
General22 hours agoNRL live updates: Newcastle Knights vs Brisbane Broncos, Wests Tigers vs North Queensland Cowboys — blog, scores and stats
-
General17 hours agoThousands flood cities demanding action on Palestine
-
General23 hours agoFinnish performer crowned Air Guitar World Champion after 25-year drought